Category: Defective Drugs
Antioxidants in Januvia May Promote Cancer Metastasis
Januvia may protect cancer cells and promote the spread of pre-existing tumors.
FDA Investigates Miscarriage Risk from Oral Diflucan
April 26, 2016 — The FDA has issued a Safety Communication to warn about a possible risk of miscarriage in pregnant women who use oral Diflucan (fluconazole) for yeast infections. The agency is evaluating results of a Danish study that...
Texas Woman Files Invokana Ketoacidosis Lawsuit
A woman from Texas who was diagnosed with ketoacidosis after using Invokana has filed a lawsuit.
European Officials Ask for Invokana Amputation Risk Data
Invokana is under investigation after a clinical trial discovered a possible increased risk of toe amputations.
Heartburn Drugs Linked to 96% Higher Risk of Kidney Failure
A study has identified that long-term use of anti-heartburn medications in the PPI class has been linked to an increased risk of kidney failure and chronic kidney disease.
Study Finds Invokana Increases Ketones in T1 Diabetics
Invokana (canagliflozin) is linked to an increased risk of diabetic ketoacidosis (DKA).
Texas Vimovo Kidney Failure Lawyer
Vimovo contains two ingredients linked to kidney failure. There is also evidence linking it to nephritis and chronic kidney disease.
Texas Vimovo Class Action Lawyer
Vimovo has been linked to higher rates of stomach cancer, kidney problems, nephritis, chronic kidney disease, and more.
FDA Investigates Kidney Failure Risks of DPP-4 Diabetes Drugs
April 12, 2016 — The FDA is evaluating the need for regulatory action based on reports of kidney failure from diabetes drugs in the DPP-4 inhibitor class. The agency has a system to flag potential safety risks based on side...
Texas Oseni Heart Failure Lawyer
Oseni combines two diabetes medications, both of which may cause or worsen heart failure.